FDA Greenlights Drug-Coated Balloon for In-Stent Restenosis

The FDA approves Boston Scientific Corporation’s AGENT Drug-Coated Balloon for treating coronary in-stent restenosis, marking the first drug-coated coronary balloon approval in the United States.